HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

POAS

Phaos Technology Holdings (Caym (AMEX)

Healthcare — Medical Devices

Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.

None
$0.31
+$0.03 (+12.54%)
Sign in to add POAS to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$5.16M
P/E Ratio (TTM)-
Forward P/E-
EPS (TTM)$-0.27
Dividend Yield-
Profit Margin-
Revenue Growth38.80%
ROE-
Debt/Equity-
Recommendation None
Analyst Target-
Analysts-
Indexes AMEX

Technical Indicators

RSI (14)49.7
Beta-
SMA 20-
SMA 40-
52-Week High$7.40
52-Week Low$0.25
50-Day Avg$1.42
200-Day Avg$2.47
Avg Volume$1.40M
Volume673.1K

Performance Analysis

NEUTRAL

POAS presents a mixed picture with both positive and negative indicators.

+ Trading near its 52-week low ($0.25), which could present a value opportunity.
~ RSI at 49.7 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ Strong revenue growth of 38.8% year-over-year.
~ Wall Street consensus is "none".

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:27 UTC

Back to Screener Export Report